9. Comparison of Total Short-chain Fatty Acids (SCFA), the Molar Proportion of SCFA, and Net Ammonia (NH3) Production In Vitro of Ryegrass Substrate (RG) Added with Different Concentrations of PSM in Experiment 3 over Time.
| absolute
concentration |
molar
proportion (mol per 100 mol of total
SCFA) |
ratios |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| treatments | SCFA | Net NH3 | acetate | butyrate | propionate | valerate | caproate | iso-butyrate | iso-valerate | A/P | AB/PV | |
| control | RG | 68.6 | 5.5 | 67.4 | 10.2 | 19.3 | 1.64 | 0.06 | 0.71 | 0.76 | 3.51 | 3.72 |
| acteoside treatments | ACT-50 | 68.8 | 4.9 | 67.0 | 10.2 | 19.7 | 1.62 | 0.19 | 0.70 | 0.70 | 3.41 | 3.63 |
| ACT-75 | 69.6 | 4.6 | 66.6 | 10.2 | 20.0 | 1.64 | 0.23 | 0.69 | 0.67 | 3.35 | 3.56 | |
| ACT-100 | 68.8 | 4.1 | 66.3 | 10.2 | 20.4 | 1.62 | 0.26 | 0.64 | 0.63 | 3.26 | 3.48 | |
| aucubin treatments | AUC-50 | 69.2 | 4.2 | 67.3 | 10.5 | 19.1 | 1.65 | 0.09 | 0.67 | 0.71 | 3.53 | 3.75 |
| AUC-75 | 68.5 | 3.6 | 66.9 | 11.0 | 18.9 | 1.73 | 0.09 | 0.67 | 0.70 | 3.54 | 3.78 | |
| AUC-100 | 65.6 | 3.0 | 66.5 | 11.4 | 18.8 | 1.76 | 0.11 | 0.67 | 0.70 | 3.54 | 3.79 | |
| combined treatment | ACT50+ AUC75 | 70.5 | 3.6 | 65.9 | 11.0 | 19.8 | 1.76 | 0.24 | 0.66 | 0.65 | 3.33 | 3.57 |
| ACT75+ AUC50 | 72.3 | 3.0 | 65.8 | 10.7 | 20.2 | 1.73 | 0.27 | 0.62 | 0.67 | 3.26 | 3.49 | |
| catalpol | CAT-50 | 70.4 | 4.2 | 67.0 | 10.5 | 19.3 | 1.71 | 0.08 | 0.69 | 0.73 | 3.47 | 3.68 |
| SEM | 1.81 | 0.92 | 0.34 | 0.31 | 0.53 | 0.13 | 0.03 | 0.01 | 0.16 | 0.09 | 0.08 | |
| treatments | <0.01 | <0.001 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | |
| time | <0.01 | <0.001 | <0.01 | <0.01 | <0.01 | 0.88 | <0.01 | <0.01 | <0.01 | <0.01 | <0.01 | |
| treatment × time | 0.38 | <0.001 | 0.05 | 0.07 | 0.07 | <0.01 | <0.01 | 0.01 | <0.01 | 0.12 | 0.51 | |
| contrasts, p value | ||||||||||||
| ACT50 + AUC75 vs (ACT-50 + AUC-75)/2 | 0.146 | 0.148 | <0.0001 | 0.003 | <0.0001 | 0.042 | <0.0001 | 0.048 | 0.021 | <0.0001 | <0.0001 | |
| ACT-50 vs AUC-75 | 0.842 | 0.029 | 0.586 | 0.005 | <0.0001 | 0.019 | <0.0001 | 0.113 | 0.833 | <0.0001 | <0.0001 | |
| ACT75 + AUC50 vs (ACT-75 + AUC-50)/2 | 0.015 | 0.004 | <0.0001 | <0.0001 | <0.0001 | 0.04 | <0.0001 | <0.0001 | 0.03 | <0.0001 | <0.0001 | |
| ACT-75 vs AUC-50 | 0.792 | 0.478 | <0.0001 | 0.177 | <0.0001 | 0.744 | <0.0001 | 0.285 | 0.002 | <0.0001 | <0.0001 | |
Total short-chain fatty acids (mmol).
Net ammonia production (mmol NH3/g DM incubated).
Acetate to propionate ratio (A/P).
[acetate + butyrate] to [propionate + valerate] (AB/PV).
Ryegrass control.
Treatments within the rows corresponding to varying doses of acteoside (denoted as ACT) and the numeric values separated by a hyphen indicating the amount of acteoside in mg/g of pasture DM.
Treatments within the rows corresponding to varying doses of aucubin (denoted as AUC) and the numeric values separated by a hyphen indicating the amount of aucubin in mg/g of pasture DM.
50 mg acteoside/g pasture DM added with 75 mg aucubin/g pasture DM.
75 mg acteoside/g pasture DM added with 50 mg aucubin/g pasture DM.
50 mg catalpol/g pasture DM.
p value of planned contrasts in selected treatments, values with the same letter within the same columns are not significant (p > 0.05),SEM: standard error of means.